Sunday, July 3, 2022

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Life-extending injection for multiple myeloma available on the NHS

Life-extending injection for multiple myeloma available on the NHS

The NHS has announced that a life-extending injection for multiple myeloma, a bone marrow cancer, will be available to 350 patients per year in...
Improving the effectiveness of the tuberculosis vaccine

Improving the effectiveness of the tuberculosis vaccine

Researchers have found a new way to enhance the tuberculosis vaccine by adding an antibody that can improve long-term effectiveness. Tuberculosis is a bacterial infection...
molnupiravir

Molnupiravir recommended by WHO to reduce COVID-19 hospitalisations

The World Health Organization (WHO) has expressed that the molnupiravir antiviral medication should be administered to patients with non-severe COVID-19 who are at an...
UK Aid funding for the development of a Zika virus vaccine

UK Aid funding for the development of a Zika virus vaccine

Scientists in Nottingham have been awarded £462,462 for the development of a Zika virus vaccine from UK Aid funding for research into vaccines for...
Insomnia treatment in women with night sweats found to be safe

Insomnia treatment for women with night sweats found to be safe

A study indicates that suvorexant, an insomnia treatment, could provide a novel therapeutic option for peri- and postmenopausal women. Hot flashes and night sweats are...
Saphnelo approved in the EU for treatment for systemic lupus erythematosus

Saphnelo approved in the EU for treatment for systemic lupus erythematosus

Saphnelo is a first-in-class type I interferon receptor antibody for patients with moderate to serve systemic lupus erythematosus. Saphnelo (anifrolumab), licensed by AstraZeneca, has been...
inhaled vaccine for COVID-19

Inhaled vaccine for COVID-19 protects against variants of concern

In a groundbreaking development toward curbing the transmission of SARS-CoV-2, scientists have developed an innovative inhaled vaccine for COVID-19 that offers robust disease protection. Pioneered...
New life-extending drug for advanced womb cancer on the NHS

New life-extending drug for advanced womb cancer on the NHS

A 30-minute treatment, the first of its kind for advanced womb cancer, is being rolled out for women across England. Womb cancer affects the womb...
cyproterone acetate

Cyproterone acetate drug may increase benign brain tumour risk

A UK study has signified that high doses of a commonly used hormonal treatment – cyproterone acetate – may elevate the risk of benign...
NHS to roll out new gene therapy for metachromatic leukodystrophy

NHS to roll out new gene therapy for metachromatic leukodystrophy

The NHS has agreed on a deal for life-saving treatment for metachromatic leukodystrophy that will offer babies and young children the prospect of a...
Should hormone replacement therapy be available without a prescription?

Should hormone replacement therapy be available without a prescription?

The MHRA has launched a public consultation on whether hormone replacement therapy (HRT) should be available from pharmacies. Hormone replacement therapy is a treatment to...
Atezolizumab now available on the NHS for lung cancer patients

Atezolizumab now available on the NHS for lung cancer patients

Thousands of lung cancer patients in England will be fast-tracked the revolutionary new drug, atezolizumab, which significantly reduces the risk of cancer returning. The Medicines...
Zika vaccine

Zika vaccine demonstrates effectiveness at preventing the virus

A groundbreaking Zika vaccine has been proven to prevent the Zika virus effectively in preclinical animal studies. The novel Zika vaccine was developed at the...
New blood cancer gene defect can be treated with existing drugs

New blood cancer gene defect can be treated with existing drugs

A blood cancer gene defect could be treated with drugs already available for cancers with similar defective genes, scientists at Queen’s University Belfast and...
Changing the lives of children with a new cystic fibrosis treatment

Changing the lives of children with a new cystic fibrosis treatment

The National Health Service (NHS) has announced a new cystic fibrosis treatment is now available, which will benefit hundreds of children. Patients in England were...
New treatment reduces effects of peanut allergy to benefit children

New treatment reduces effects of peanut allergy to benefit children

Thousands of children and young people will receive pioneering treatment for peanut allergy after NHS England secured the first deal of its kind in...
Phenylketonuria (PKU) drug now available to patients in England

Phenylketonuria (PKU) drug now available to patients in England

The NHS has agreed to a deal to secure a drug for Phenylketonuria (PKU), a rare, deliberating disorder for patients of all ages for...
Drug may effectively help patients with COVID pneumonia

Drug may effectively help patients with COVID pneumonia

A proof-of-concept trial led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may benefit some...
spinal cord injuries

NervGen: A new hope for treating spinal cord injuries

For decades, medical researchers have struggled in vain to solve the mystery of how to reverse paralysis caused by serious spinal cord injuries. Finally, hope...
New covid treatment cuts hospitalisation and death by 79%

New covid treatment cuts hospitalisation and death by 79%

The UK regulator, Medicines and Healthcare products Regulatory Agency (MHRA), has authorised Xevudy (sotrovimab) as a covid treatment for people at high risk of...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest